Press Releases


Taconic Biosciences Launches European Production of Diet Induced Obesity Model

Rensselaer, NY — June 12, 2018 - Taconic Biosciences, a global leader in providing genetically engineered mouse model and service solutions, has launched local production of the Taconic diet induced obesity (DIO) model in Europe. DIO mice are used to study metabolic disease and obesity because they exhibit elevated glucose, insulin, cholesterol, leptin, and corticosterone, thus mimicking many aspects and complications of human metabolic disease. The Diet...

Read More

Scientist.com and Taconic Biosciences Offer Online Access to Next Generation Easi-CRISPR Technology

Researchers can now access Taconic Easi-CRISPR rodent models on the Scientist.com online marketplace San Diego, CA — May 21, 2018 - Scientist.com, the life science industry's leading online marketplace for outsourced research, announced today that it has partnered with Taconic Biosciences, a global leader in providing genetically engineered rodent model and service solutions. Pharmaceutical and biotech users of the Scientist.com marketplace can now purchase rodent models generated...

Read More

Taconic Biosciences Licenses Easi-CRISPR Technology from the University of Nebraska

Rensselaer, NY — April 20, 2018 - Taconic Biosciences, a global leader in providing genetically engineered mouse model and service solutions, has been granted a license to the Easi-CRISPR technology from the University of Nebraska. Easi-CRISPR was developed in the laboratories of Drs. Masato Ohtsuka (Tokai University in Japan), and Channabasavaiah Gurumurthy (University of Nebraska). The terms of the agreement include a world-wide, non-exclusive license to the...

Read More

Taconic Biosciences Launches New Inflammatory Bowel Disease Models

Rensselaer, NY — April 19, 2018 - Taconic Biosciences, a global leader in providing genetically engineered mouse model and service solutions, announces the launch of several new inflammatory bowel disease (IBD) animal models. As a fully-licensed provider of CRISPR/Cas9 gene editing technology, Taconic scientists knocked out the mouse Il10 gene to generate a spontaneous colitis mouse models. The new knockout models were created on Taconic's B6 (C57BL/6NTac)...

Read More

Taconic Biosciences Announces the Formation of Scientific Advisory Board

Rensselaer, NY — February 21, 2018 - Taconic Biosciences, a global leader in genetically engineered mouse models and associated services, announced the formation of its Scientific Advisory Board (SAB) with the initial appointments of J. Victor Garcia, PhD, Andrew Goodman, PhD, and David Hill, PhD. The SAB will collaborate with Taconic's management in providing scientific insight and guidance on the evolution of the company's product and service...

Read More

Taconic Biosciences Launches New Tagline, Celebrating Commitment to Customers and the Microbiome

Hudson, NY — October 6, 2017 - Taconic Biosciences, a global leader in genetically engineered rodent models and associated services, announces the launch of a new tagline: "Models For Life™." Introducing a fresh interpretation of Taconic's brand and 65 year history, the new tagline celebrates Taconic's unparalleled commitment to its customers and industry leading microbiome products and services. The new 'Models For Life' tagline sits at the...

Read More

Taconic Biosiences Sponsors Custom Model to Support Kabuki Syndrome, a Rare Disorder Causing Intellectual Disability

Hudson, NY — August 31, 2017 - Taconic Biosciences, a global leader in genetically engineered rodent models and associated services, is funding the development of a custom mouse model to study Kabuki syndrome, a rare genetic disorder. Taconic is donating model generation services as a third-time sponsor of the Rare Disease Science Challenge, BeHEARD. Hosted by the Rare Genomics Institute, the Rare Disease Science Challenge is an...

Read More

Taconic Biosciences Plans to Relocate Headquarters to Albany, NY Area

Hudson, NY — August 23, 2017 - Taconic Biosciences announces plans to move its corporate headquarters up the Hudson River from Hudson to the Albany, NY area at the end of 2017. The new location is near several existing Taconic facilities in Rensselaer, 45 miles from its primary operations facility in Germantown, NY, and accessible to all global locations. With Taconic's increasing prominence within the global pharmaceutical...

Read More

Taconic Biosciences Announces Partnership with Cergentis B.V. to Provide Transgene Mapping Services

Hudson, NY — August 8, 2017 - Taconic Biosciences, a global leader in genetically engineered mouse models and associated services, announced it has signed a collaborative agreement with Cergentis B.V. ("Cergentis") to leverage the company's Targeted Locus Amplification (TLA) technology to provide transgene mapping services to its customers. While transgenic mice generated via random pro-nuclear injection (PNI) continue to be a critical tool in biomedical research, a...

Read More

Taconic Biosciences and Pharmatest Services LTD Create First Human Immune System Model for Bone Metastasis

Researchers hopeful this new model will address incurable and painful disease Hudson, NY — July 5, 2017 - Taconic Biosciences, a global leader in genetically engineered mouse models and associated services, announced it has signed a collaborative agreement with Pharmatest Services, Ltd. ("Pharmatest") to leverage the company's oncology and skeletal disease preclinical efficacy services using Taconic's humanized mouse models. Bone metastasis develops when cancer spreads from elsewhere...

Read More